TEM is up 6.63% today. Volume is 3.90M vs a 30-day average of 6.88M (0.57x).
Tempus AI, Inc. is scheduled to report earnings Mon, Nov 2, 2026 · before open. Analysts expect EPS of $-0.08 on revenue of about $413.44M. Stocks often move sharply on earnings day.
Tempus AI (TEM) just deepened its ties with Bristol Myers Squibb and Pathos AI, securing long-term data licensing deals that spotlight its role in real-world oncology and neurosci…
Tempus (TEM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CHICAGO, October 26, 2026--Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union’s In Vitro Diagnostic Regulation (IV…
HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target from $66 to $68.
BTIG analyst Mark Massaro reiterates Tempus AI (NASDAQ:TEM) with a Buy and maintains $80 price target.